C3 and hemolytic-uremic syndrome: Decreased levels of C3 and C4 have been reported in numerous Sp-HUS patients, in the acute phase, that reflect activation and consumption of both classical (CP) and alternate (AP) complement pathways [92,93,94,95,96].